Jules Haimovitz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jules Haimovitz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jules Haimovitz. Jules Haimovitz is a Director in Armata Pharmaceuticals, Inc. ($APHB) and a Director in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in BLUCORA, INC. ($BCOR) and a Director in Innoviva, Inc. ($THRX).
Address: 601 108TH AVENUE NE, SUITE 1200 BELLEVUE 98004 WA
Companies in which Jules Haimovitz is an Insider
ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jules Haimovitz: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jules Haimovitz: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 05 2021
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BLUCORA, INC.
Industry: FINANCE SERVICES [6199]
Position of Jules Haimovitz: Director
Holdings: 13,500 shares
Current Value: $203,850
Latest Transaction: Jun 01 2012
$BCOR Market Capitalization: $613.27M
$BCOR Previous Close: $15.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jules Haimovitz: Director
Holdings: 87,764 shares
Latest Transaction: May 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jules Haimovitz
Sentiment: All, ARIA, APHB, BCOR, THRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | THRX | Innoviva, Inc. | Haimovitz Jules | Director | Grant | A | 0.00 | 17,482 | 0 | 87,764 | 70.3 K to 87.8 K (+24.87 %) |
| Apr 05 2021 | APHB | Armata Pharmaceuti ... | Haimovitz Jules | Director | Option Exercise | A | 4.74 | 30,000 | 142,200 | 30,000 | |
| Apr 28 2020 | THRX | Innoviva, Inc. | Haimovitz Jules | Director | Grant | A | 0.00 | 16,917 | 0 | 70,282 | 53.4 K to 70.3 K (+31.70 %) |
| May 24 2019 | THRX | Innoviva, Inc. | Haimovitz Jules | Director | Grant | A | 0.00 | 16,399 | 0 | 53,365 | 37 K to 53.4 K (+44.36 %) |
| Apr 26 2018 | THRX | Innoviva, Inc. | Haimovitz Jules | Director | Grant | A | 0.00 | 14,249 | 0 | 36,966 | 22.7 K to 37 K (+62.72 %) |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Haimovitz Jules | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Haimovitz Jules | Director | Option Exercise | D | 6.65 | 75,000 | 498,750 | 0 |